Issue 17.1

Innovative nursing practices

Hello and welcome to the first issue of 2017. I am really excited about this issue, which is full of, what we hope are, interesting and challenging articles.

Elizabeth Foote
HIV Clinical Nurse Specialist

Continuing Professional Developement (CPD): Cardiovascular disease and HIV

The first of a series of four articles providing an opportunity to earn CPD points. Among the many comorbidity conditions, cardiovascular disease (CVD) has become an area of particular concern in the field of HIV. The high prevalence of cardiovascular risk factors in people living with HIV, alongside the growing evidence of HIV-accelerated inflammatory processes, known to promote atherosclerosis, presents an ongoing challenge. This article has been prepared to aid your continuing professional development and with revalidation in mind.

HIV Nursing 2017; 17: 3–15.

Juliet Bennett
Independent Nurse Advisor

Innovation in HIV nursing: the Liverpool Community Clinic

The Liverpool Community Clinic (LCC) was established to address the pressing problem of non-attendance to hospital by people who are living with HIV (PLWH). This group now receives timely, safe and appropriate care while being managed remotely. The aims of the LCC are to reduce hospital admissions, manage side effects, guarantee medication and adherence, identify psychosocial factors that impact on engagement and retention in care, and enable person-centred care incorporating shared decision making.

HIV Nursing 2017; 17: 16–19.

Pauline Jelliman
Operational and Clinical lead for TB and HIV

HIV among people using anabolic steroids in the United Kingdom: an overview

Since the mid-1980s, preventing HIV transmission among people who inject drugs (PWIDs) has been one of the cornerstones of the UK’s response to HIV. The early comprehensive implementation of harm reduction, particularly needle and syringe programmes, has been widely acknowledged as key to a low prevalence of HIV among PWIDs in the UK. However, this harm-reduction strategy was developed to avert an HIV epidemic among people injecting heroin and while the prevalence in this population remains low, it is clear that there are now emerging populations of PWIDs with different patterns of drug use and risks.

HIV Nursing 2017; 17: 20–23.

Geoff Bates, Vivian Hope, Jim McVeigh
Researcher, Public Health Institute,Public Health Institute,Public Health Institute

Treatment of HIV associated lipoatrophy: more than just skin deep

With increased survival rates and individuals living with long-term treatment regimens, side effects of HAART have become more evident . One widely documented side effect of HAART is lipodystrophy in which body fat is redistributed as a result of lipohypertrophy of fat of the viscera, neck and breast and lipoatrophy of subcutaneous fat. Facial wasting has serious implications for an HIV-positive person’s self-confidence and quality of life due to the stigmatising nature of the condition and its association with HIV. In order to counteract the stigmatising nature of the condition, New Fill, which is a polylactic acid treatment, is injected to cover the buccal and/or temporal fat pads to improve facial appearance. The New Fill clinic at North Manchester General Hospital is a nurse-led service that is a once-weekly clinic offering this service to patients in the North West.

HIV Nursing 2017; 17: 24–26.

Michelle Croston & Jennifer Cawsey
Manchester Metropolitan University & North Manchester General Hospital

Pop it up! The suitability and acceptability of community-based pop-up sexual health screening for men who have sex with men

Bournemouth has one of the highest rates of HIV in the UK, a diverse community associated with high rates of partner change and complex, hard-to-reach sexual networks. However, an emphasis has now been placed on the availability of community-based screening programmes in order to increase testing coverage [3] particularly among identified most at-risk populations (MARPs).

HIV Nursing 2017; 17: 27–30.

Kevin Turner
Sexual health advisor

HIV Nursing

Sharing best practice in HIV care

Published by Mediscript Ltd


  • Mediscript Ltd 1 Mountview Court. 310 Friern Barnet Lane. London , N20 OLD.


Company Information

Registration name: Mediscript Ltd
Place of registration: Whetstone London, UK
Company registration No. : 2128686
Tel: 0208 446 8898
Contact Name : Ms Fatima Patel

Currently,​ we can accept payments in the following currencies through our website: